Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid
Guirong Lianga,1, Hua Qianb,c,1, Chao Sund,1, Hanmei Zhanga,1, Zhiliang Lia,1, Suo Lia,1, Ke Jinga,1, Chenjing Zhaoa,1, Yuan Wange,1, Ruiyu Xianga,1, Xiaoguang Lib,c,1,
Corresponding author
liqian0041@139.com

Corresponding authors.
, Suying Fenga,1,
Corresponding author
fengsy@pumcderm.cams.cn

Corresponding authors.
a Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
b School of Public Health and Laboratory Medicine, Hunan University of Medicine, Huaihua, Hunan, China
c Department of Laboratory Medicine, Medical College, Dalian University, Dalian, Liaoning, China
d Department of Dermatology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China
e Department of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
Read
3
Times
was read the article
0
Total PDF
3
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 3 0 3

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.